Literature DB >> 1565363

Pain symptoms associated with endometriosis.

L Fedele1, S Bianchi, L Bocciolone, G Di Nola, F Parazzini.   

Abstract

We evaluated the prevalence and severity of dysmenorrhea, pelvic pain, and deep dyspareunia and their relation to disease stage and site in 124 infertile women with endometriosis and 67 infertile women with normal findings. Seventy-eight endometriosis patients had stages I-II disease and 46 had stages III-IV. The frequency of dysmenorrhea was similar in patients and controls; pelvic pain was more frequent only in patients with stages III-IV, whereas deep dyspareunia was more prevalent regardless of disease stage. Dysmenorrhea was significantly more severe in stages III-IV patients than in either stages I-II patients or controls. Pelvic pain was more severe in stages III-IV, but we observed a statistically significant difference only in comparison with stages I-II. An association of two or more pain symptoms was more frequent in women with endometriosis than in those with normal pelves (relative risk = 3.1, 95% confidence interval 1.52-6.46). Ovarian endometriomas were the only lesions significantly associated with severe dysmenorrhea and pelvic pain. We conclude that endometriosis in infertile women causes pelvic pain, the severity of which is related to the extent of the disease.

Entities:  

Mesh:

Year:  1992        PMID: 1565363

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  13 in total

1.  Prostaglandin E2 receptor EP1 in healthy and diseased human endometrium.

Authors:  Junyan Zhu; Doris Mayr; Christina Kuhn; Sven Mahner; Udo Jeschke; Viktoria von Schönfeldt
Journal:  Histochem Cell Biol       Date:  2017-11-13       Impact factor: 4.304

2.  Symptoms-Based Phenotypes Among Women With Dysmenorrhea: A Latent Class Analysis.

Authors:  Chen X Chen; Susan Ofner; Giorgos Bakoyannis; Kristine L Kwekkeboom; Janet S Carpenter
Journal:  West J Nurs Res       Date:  2017-09-15       Impact factor: 1.967

Review 3.  The peritoneum--an important factor for pathogenesis and pain generation in endometriosis.

Authors:  Maria-Luisa Barcena de Arellano; Sylvia Mechsner
Journal:  J Mol Med (Berl)       Date:  2014-03-05       Impact factor: 4.599

4.  Optimal management of chronic cyclical pelvic pain: an evidence-based and pragmatic approach.

Authors:  Ha Ryun Won; Jason Abbott
Journal:  Int J Womens Health       Date:  2010-08-20

5.  Pain typology and incident endometriosis.

Authors:  K C Schliep; S L Mumford; C M Peterson; Z Chen; E B Johnstone; H T Sharp; J B Stanford; A O Hammoud; L Sun; G M Buck Louis
Journal:  Hum Reprod       Date:  2015-08-11       Impact factor: 6.918

6.  What to choose and why to use - a critical review on the clinical relevance of rASRM, EFI and Enzian classifications of endometriosis.

Authors:  G Hudelist; L Valentin; E Saridogan; G Condous; M Malzoni; H Roman; D Jurkovic; J Keckstein
Journal:  Facts Views Vis Obgyn       Date:  2021-12

7.  Laparoscopic management of moderate: Severe endometriosis.

Authors:  Pranay R Shah; Anu Adlakha
Journal:  J Minim Access Surg       Date:  2014-01       Impact factor: 1.407

8.  Relationship between the severity of endometriosis symptoms (dyspareunia, dysmenorrhea and chronic pelvic pain) and the spread of the disease on ultrasound.

Authors:  Elham Kor; Seyed Reza Saadat Mostafavi; Zahra Ahmadian Mazhin; Adeleh Dadkhah; Anis Kor; Shirin Habibi Arvanagh; Shima Ghafourian Noroozi; Ghazal Sadri
Journal:  BMC Res Notes       Date:  2020-11-25

9.  Telocytes Enhances M1 Differentiation and Phagocytosis While Inhibits Mitochondria-Mediated Apoptosis Via Activation of NF-κB in Macrophages.

Authors:  Yue-Lin Huang; Fei-Lei Zhang; Xue-Ling Tang; Xiao-Jun Yang
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

10.  Effect of Surgical Removal of Endometriomas on Cyclic and Non-cyclic Pelvic Pain.

Authors:  Murat Api; Aysen Telce Boza; Semra Kayatas; Mustafa Eroglu
Journal:  Int J Fertil Steril       Date:  2015-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.